Lupus Foundation of America20h
New Study Identifies Predictors of Successful Glucocorticoid Discontinuation in Systemic Lupus Erythematosus Treatment
A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can ...
Lupus Foundation of America6d
Coping with the Mental Health Impacts of Lupus
Living with lupus can significantly affect your mental health. This January we are honoring Mental Wellness Month by exploring the intersection of lupus and mental health with a four-part series of ...
Lupus Foundation of America8d
UPDATE: Phase 1 Trial Begins for Investigational Therapy, CB-010, for Lupus Nephritis Treatment
The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.
Lupus Foundation of America9d
New Study Suggests KLF2 May Play a Role in Neutrophil Regulation and the Development of Systemic Lupus Erythematosus
Neutropenia, a condition characterized by low neutrophil levels, is common in individuals with systemic lupus erythematosus (SLE) and can lead to severe infections. A new study investigates the role ...
Lupus Foundation of America9d
Exagen Inc. Gains Approval for Advanced Lupus and Rheumatoid Arthritis Diagnostic Tests
Exagen Inc. has announced conditional approval from the New York State Department of Health for its innovative new biomarker ...
Lupus Foundation of America9d
New Study Finds Systemic Lupus Erythematosus is a Risk Factor for Developing Multiple Cutaneous Lupus Erythematosus Subtypes
Lupus affects different people in different ways, and skin problems like rashes or sores are common. In a new study, people with systemic lupus erythematosus (SLE) were found to be at higher risk for ...